PMID- 35450412 OWN - NLM STAT- MEDLINE DCOM- 20220425 LR - 20220716 IS - 1942-0994 (Electronic) IS - 1942-0900 (Print) IS - 1942-0994 (Linking) VI - 2022 DP - 2022 TI - alpha-Lipoic Acid-Plus Ameliorates Endothelial Injury by Inhibiting the Apoptosis Pathway Mediated by Intralysosomal Cathepsins in an In Vivo and In Vitro Endothelial Injury Model. PG - 8979904 LID - 10.1155/2022/8979904 [doi] LID - 8979904 AB - alpha-Lipoic acid-plus (LAP), an amine derivative of alpha-lipoic acid, has been reported to protect cells from oxidative stress damage by reacting with lysosomal iron and is more powerful than desferrioxamine (DFO). However, the role of LAP in experimental carotid artery intimal injury (CAII) has not yet been well investigated. Therefore, we sought to uncover the role and potential endovascular protective mechanisms of LAP in endothelial injury. In vitro, oxyhemoglobin (OxyHb) stimulation of cultured human umbilical vein endothelial cells (HUVECs) simulated intimal injury. In vivo, balloon compression injury of the carotid artery was used to establish a rat CAII model. We found that the protein levels of cathepsin B/D, ferritin, transferrin receptor (TfR), cleaved caspase-3, and Bax increased in the injured endothelium and HUVECs but were rectified by DFO and LAP treatments, as revealed by western blotting and immunofluorescence staining. Additionally, DFO and LAP decreased oxidative stress levels and endothelial cell necrosis of the damaged endothelium. Moreover, DFO and LAP significantly ameliorated the increased oxidative stress, iron level, and lactic dehydrogenase activity of HUVECs and improved the reduced HUVEC viability induced by OxyHb. More importantly, DFO and LAP significantly reduced mitochondrial damage and were beneficial for maintaining lysosomal integrity, as indicated by acridine orange (AO), Lyso-Tracker Red, JC-1, and ATPB staining in HUVECs. Finally, LAP might offer more significant endovascular protective effects than DFO. Our data suggested that LAP exerted endovascular protective effects by inhibiting the apoptosis signaling pathway mediated by intralysosomal cathepsins by reacting with excessive iron in endothelial lysosomes after intimal injury. CI - Copyright (c) 2022 Yang Wang et al. FAU - Wang, Yang AU - Wang Y AD - Department of Neurosurgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, No. 17 Lujiang Road, Hefei, 230001 Anhui Province, China. FAU - Bao, Dejun AU - Bao D AD - Department of Neurosurgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, No. 17 Lujiang Road, Hefei, 230001 Anhui Province, China. FAU - Dong, Yongfei AU - Dong Y AD - Department of Neurosurgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, No. 17 Lujiang Road, Hefei, 230001 Anhui Province, China. FAU - Wei, Xiangpin AU - Wei X AD - Department of Neurosurgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, No. 17 Lujiang Road, Hefei, 230001 Anhui Province, China. FAU - Yu, Jian AU - Yu J AUID- ORCID: 0000-0003-3809-3823 AD - Department of Neurosurgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, No. 17 Lujiang Road, Hefei, 230001 Anhui Province, China. FAU - Niu, Chaoshi AU - Niu C AUID- ORCID: 0000-0001-8508-567X AD - Department of Neurosurgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, No. 17 Lujiang Road, Hefei, 230001 Anhui Province, China. AD - Anhui Province Key Laboratory of Brain Function and Brain Disease, No. 17 Lujiang Road, Hefei, 230001 Anhui Province, China. LA - eng PT - Journal Article DEP - 20220412 PL - United States TA - Oxid Med Cell Longev JT - Oxidative medicine and cellular longevity JID - 101479826 RN - 73Y7P0K73Y (Thioctic Acid) RN - E1UOL152H7 (Iron) SB - IM MH - Animals MH - Apoptosis MH - Endothelium/metabolism MH - Human Umbilical Vein Endothelial Cells/metabolism MH - Humans MH - Iron/metabolism MH - Oxidative Stress MH - Rats MH - *Thioctic Acid/metabolism/pharmacology PMC - PMC9018191 COIS- The authors declare that there are no conflicts of interest. EDAT- 2022/04/23 06:00 MHDA- 2022/04/26 06:00 PMCR- 2022/04/12 CRDT- 2022/04/22 06:42 PHST- 2021/10/10 00:00 [received] PHST- 2022/01/27 00:00 [revised] PHST- 2022/02/23 00:00 [accepted] PHST- 2022/04/22 06:42 [entrez] PHST- 2022/04/23 06:00 [pubmed] PHST- 2022/04/26 06:00 [medline] PHST- 2022/04/12 00:00 [pmc-release] AID - 10.1155/2022/8979904 [doi] PST - epublish SO - Oxid Med Cell Longev. 2022 Apr 12;2022:8979904. doi: 10.1155/2022/8979904. eCollection 2022.